Unknown

Dataset Information

0

Novel microarray design for molecular serotyping of shiga toxin- producing Escherichia coli strains isolated from fresh produce.


ABSTRACT: Serotyping Escherichia coli is a cumbersome and complex procedure due to the existence of large numbers of O- and H-antigen types. It can also be unreliable, as many Shiga toxin-producing E. coli (STEC) strains isolated from fresh produce cannot be typed by serology or have only partial serotypes. The FDA E. coli identification (FDA-ECID) microarray, designed for characterizing pathogenic E. coli, contains a molecular serotyping component, which was evaluated here for its efficacy. Analysis of a panel of 75 reference E. coli strains showed that the array correctly identified the O and H types in 97% and 98% of the strains, respectively. Comparative analysis of 73 produce STEC strains showed that serology and the array identified 37% and 50% of the O types, respectively, and that the array was able to identify 16 strains that could not be O serotyped. Furthermore, the array identified the H types of 97% of the produce STEC strains compared to 65% by serology, including six strains that were mistyped by serology. These results show that the array is an effective alternative to serology in serotyping environmental E. coli isolates.

SUBMITTER: Lacher DW 

PROVIDER: S-EPMC4148803 | biostudies-literature | 2014 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Novel microarray design for molecular serotyping of shiga toxin- producing Escherichia coli strains isolated from fresh produce.

Lacher David W DW   Gangiredla Jayanthi J   Jackson Scott A SA   Elkins Christopher A CA   Feng Peter C H PC  

Applied and environmental microbiology 20140801 15


Serotyping Escherichia coli is a cumbersome and complex procedure due to the existence of large numbers of O- and H-antigen types. It can also be unreliable, as many Shiga toxin-producing E. coli (STEC) strains isolated from fresh produce cannot be typed by serology or have only partial serotypes. The FDA E. coli identification (FDA-ECID) microarray, designed for characterizing pathogenic E. coli, contains a molecular serotyping component, which was evaluated here for its efficacy. Analysis of a  ...[more]

Similar Datasets

| S-EPMC6211345 | biostudies-literature
| S-EPMC1951031 | biostudies-literature
| S-EPMC5583481 | biostudies-literature
| S-EPMC6838620 | biostudies-literature
| S-EPMC5334574 | biostudies-literature
| S-EPMC7498430 | biostudies-literature
| S-EPMC2681110 | biostudies-literature
| S-EPMC11489412 | biostudies-literature
| S-EPMC86746 | biostudies-literature
| S-EPMC356890 | biostudies-literature